Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CTT Pharmaceutical Holdings Inc CTTH

CTT Pharmaceutical Holdings, Inc. is a development stage company. The Company is specialized in drug delivery systems technology within the pharmaceutical industry. The Company is focused is on fast dissolving drug delivery systems through the development of advanced oral delivery thin wafers. The Company plans to specialize in the development of oral drug delivery systems for pain management and treatment. Film strip encapsulated with the actives to help in pain reduction can include many combinations to help reduce pain and addiction and help patient safely. Oral Thin strips helps in pain management and inflammation indications, such as Arthritis. The Company has invented an ideal intra oral, fast-dissolving drug delivery system. This novel intraoral drug delivery system is its proprietary patented technology and is a thin, flexible and quick-dissolving film.


OTCPK:CTTH - Post by User

Post by markenurhon Jun 25, 2024 12:09pm
48 Views
Post# 36105147

CTT Pharma Gives Update on NSF Grant

CTT Pharma Gives Update on NSF Granthttps://www.thenewswire.com/press-releases/1kWVFPgEm-ctt-pharma-gives-update-on-nsf-grant-for-smoke-reduction-technology.html

The NSF grant program is highly competitive as it receives over 12,000 applicants annually from companies that have innovations that could help society. CTT successfully made it past the first round process and is among a few thousand remaining applicants. These remaining applicants have several deadlines over the course of the year to file a full proposal into the grant program. CTT successfully met the March 4th deadline and is anticipating an answer in the last week of August or the first week of September. Successful entry into the all three phases with the NSF grant program would allow CTT funding for the creation of our technology, research/testing, and mass production of our low dose fast acting dissolvable nicotine strips.  


<< Previous
Bullboard Posts
Next >>